Your session is about to expire
← Back to Search
Behavioural Intervention
Photobiomodulation for Cancer-Related Cognitive Impairment
N/A
Waitlist Available
Research Sponsored by Arash Asher, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-month follow up
Awards & highlights
Study Summary
This trial tests a helmet to see if it can improve cognitive symptoms in cancer survivors with cancer-related cognitive impairment. 30 participants will take part, with 15 in each group (intervention & control). Self-report questionnaires will be used to measure improvements.
Who is the study for?
This trial is for adult cancer survivors who've finished treatment between 6 months and 5 years ago, are experiencing cognitive issues, and can read English or Spanish. It's not for those pregnant, nursing, with certain neurological conditions, previous brain tumors/CNS metastasis, or past use of specific advanced cancer treatments.Check my eligibility
What is being tested?
The study tests if a THOR LED Photobiomodulation helmet improves cognition in cancer survivors when used thrice weekly for six weeks. Participants are randomly assigned to either the therapeutic setting (active) group or placebo setting (inactive) group.See study design
What are the potential side effects?
Since this is a non-invasive therapy using light from a helmet, side effects might be minimal but could include discomfort at the site of application or sensitivity to the light.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1-month follow up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-month follow up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Cognitive Symptoms
Secondary outcome measures
Anxiety
Cognitive Abilities
Depression
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Intervention Arm - Therapeutic SettingExperimental Treatment1 Intervention
Photobiomodulation Helmet, Therapeutic setting, 35mW/cm2 = 42J/cm2, 3 x Sessions per week for 6 weeks
Group II: Control Arm - Non-Therapeutic SettingPlacebo Group1 Intervention
Photobiomodulation Helmet, Non-Therapeutic setting, 0mW/cm cm2 = 0J/cm2, 3 x Sessions per week for 6 weeks
Find a Location
Who is running the clinical trial?
Thor PhotomedicineUNKNOWN
Arash Asher, MDLead Sponsor
3 Previous Clinical Trials
49 Total Patients Enrolled
ThorUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I was previously diagnosed with a stage I-III non-brain solid tumor or lymphoma.I have never had a brain tumor or cancer spread to my brain.I have had treatments like spinal chemotherapy, CAR-T therapy, or a bone marrow transplant.I am 18 years old or older.I have a neurological condition like Alzheimer's, Parkinson's, or MS affecting my thinking.I finished my cancer treatment between 6 months and 5 years ago, but I may still be on certain maintenance therapies.I am currently using light therapy for treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention Arm - Therapeutic Setting
- Group 2: Control Arm - Non-Therapeutic Setting
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any openings for enrollees in this clinical trial?
"The clinicaltrials.gov database indicates that this trial, which was originally posted on July 1st 2023 and last updated in May 4th of the same year, is not actively searching for participants. However, 592 other trials are currently open to enrollment at present."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger